Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...

Why Your Back Is Doing a Job It Was Never Meant to Do The lumbar spine is a load-bearing structure, not a load-moving one.

Both space and ageing can cause atrophy of a "forgotten" muscle.

A study has found that restorative neurostimulation continues to be effective in treating low-back pain caused by multifidus dysfunction after three years. This type of dysfunction occurs when the ...

The US Food and Drug Administration (FDA) has approved an implantable neurostimulation system (ReActiv8, Mainstay Medical) to treat intractable chronic low back pain associated with multifidus muscle ...

The novel design of a deep muscle along the spinal column called the multifidus muscle may in fact be key to spinal support and a healthy back, according to researchers at the University of California ...

“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...

Please provide your email address to receive an email when new articles are posted on . Results published in Orthopedics showed facet joint osteoarthritis was associated with a higher multifidus ...

We have updated our Privacy Policy. Please review to learn more. By continuing to use our services, you agree to these updates. By Blake Stilwell Published Aug 28 ...

Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...